In recent years, you may have seen headlines like: Weight-loss or diabetes drug may reduce dementia risk. The drugs in question are GLP-1 receptor agonists (GLP-1 RAs) such as Semaglutide (Ozempic/Wegovy), Liraglutide (Victoza/Saxenda), and others
Loguercio, C., & Di Pierro, M
10.1093/eurheartj/ehab467 144
Dopamine & Reward Pathways By modulating dopamine signalling, Tesofensine has drawn interest from researchers studying reward-driven eating and food cravings a fundamentally different approach from gut hormone compounds
Survival and Recurrence With GLP-1 Receptor Agonists in Breast Cancer
Beyond Weight Loss: The Longevity Revolution While GLP-1 medications like tirzepatide have gained widespread attention for their remarkable weight loss results, emerging research reveals their potential to address aging-related diseases and expand healthy lifespan